Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery - Wikidata - awgldk - TriplyDB

Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery

Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery

http://www.wikidata.org/entity/Q35112054

about

Statistical Issues in the Design and Analysis of nCounter Projects Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm.Development and verification of the PAM50-based Prosigna breast cancer gene signature assay A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma.Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform.Gastrointestinal malignancies harbor actionable MET exon 14 deletions.Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability.Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion.Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.Surgical margins in the veterinary cancer patient.Genomics Study of Gastric Cancer and Its Molecular Subtypes.Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study Development of mesenchymal subtype gene signature for clinical application in gastric cancer.Identification and validation of a prognostic 9-genes expression signature for gastric cancer.Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity.Identification of a prognostic 5-Gene expression signature for gastric cancer.Combination of TNM staging and pathway based risk score models in patients with gastric cancer.Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability.Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer.Gene expression and prognosis of NOX family members in gastric cancer.Computational measurement of tumor immune microenvironment in gastric adenocarcinomas Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines

P2860

Q26828619-5741839D-62EF-4F53-A289-B0DD73966ED6 Q33591789-8BA03946-CB20-4A33-89FF-537DD44B2E77 Q35752868-1C0901FC-0F16-474D-BD85-55CBC73C5BB5 Q35920803-563F1229-8BA5-45D5-A148-D5BF63A91F2C Q36215720-8C284DB2-CA60-45DA-9D5C-F496A89CD250 Q36414027-19DD5807-F150-4337-88D6-8DC96D8E91AD Q36414458-27C282FB-B3A9-414F-B1CF-01A60713E0E4 Q36710911-3B44ECA3-BCE3-4735-9AC6-43910CBDF206 Q37660522-3842E6B9-03D0-46BF-9293-18EABBAEDB65 Q37706604-BE06DC6C-D252-4A06-9261-7D5B6A8826D9 Q37716485-C1BAAA93-6232-460C-B428-0B0A949A104B Q38659483-B5E19EC6-E53C-4825-9081-D5CCD3AAB61D Q38757865-CD2E504D-7393-407C-B72B-E745428C9B62 Q38826577-19ED7759-8E70-475A-AD72-4B052517A9E3 Q41038524-31D28D92-FC46-4AEE-A649-A38B7A4CAA2E Q41340592-F13A46DB-CDF4-4B1A-9F81-91E3A874F987 Q42371631-044EDFC6-4FAA-4B9A-863D-EACC54350587 Q47240879-89117F04-C7E6-46F3-B681-9038F2CB9CBB Q47577423-66AEFF5C-EFB4-484D-9D10-F7771CD98454 Q48026879-B33B148F-4C2B-4A91-992F-39177E838059 Q48134310-B2A270B3-7EAB-4746-A509-980408794D5B Q54238201-6C4AB95E-2A6D-4BE8-AE8D-7DC3BAABBF21 Q54938715-1EBEF823-A722-4FF1-8168-ECE911EA3CD6 Q55077233-D2EAA84E-D604-461B-B0FB-C832D22C64F0 Q55186854-998301C2-F418-42BF-AA17-5378E8DE0CDE Q58734129-D9DFFBF4-A291-48F6-B980-0E8B45F6A8DA Q58741167-48517D97-E626-4D24-81BD-ED8460E7A5AC

P2860

Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery

http://www.wikidata.org/entity/Q35112054

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Nanostring-based multigene ass ...... cancer patients after surgery

@ast

Nanostring-based multigene ass ...... cancer patients after surgery

@en

type

label

Nanostring-based multigene ass ...... cancer patients after surgery

@ast

Nanostring-based multigene ass ...... cancer patients after surgery

@en

prefLabel

Nanostring-based multigene ass ...... cancer patients after surgery

@ast

Nanostring-based multigene ass ...... cancer patients after surgery

@en

P1433

Q35112054-227386CE-6A9C-4F4B-A9AF-B1A80C547D5D

P1476

Q35112054-B5A170F9-73D3-47A7-AD2A-4E47667460DC

P2093

Q35112054-057390CB-7A10-4F35-8F6E-3BF22C1A16A3

Q35112054-1076D3FC-6DC7-48B0-9FB1-7C817213CE9C

Q35112054-1F0B5565-0231-4EF0-87A2-36A4E395E805

Q35112054-2A463377-B740-4ACE-9DAF-32CCED8C543C

Q35112054-3A35142B-A586-4401-8DAB-7176634DEAE3

Q35112054-3CFD0BA2-F932-452C-B8DD-48A69F48EEEB

Q35112054-503B14DC-BF85-40E0-83A6-93DCEF0DAD3D

Q35112054-5D09F4B7-0E88-43FB-B15C-2C823B41CE61

Q35112054-78C13B90-82C4-45B7-BA6F-723592F4AD6A

Q35112054-7A83C127-F3BD-43FF-B752-EBED0F666B4D

P2860

Q35112054-0EDD6801-A350-4CCD-9A82-14FF8D5487E2

Q35112054-2C3EA1BE-3B6E-45DA-B990-7B8EE73F3E0F

Q35112054-47ADF934-1038-4A3C-A3A6-5219EA3DFA6D

Q35112054-4967AA79-927F-4BFC-8E1D-BEE9E05223F8

Q35112054-4F679F62-EFDE-4EC2-8AF5-89FA2FBCAF41

Q35112054-58FA6CB9-92F1-41B2-BC66-2E0807F1D6AC

Q35112054-5B10A1E7-9F92-4EEC-A0CC-ACCB254450B8

Q35112054-5F90C1ED-E849-42EE-9519-D120CC45F92D

Q35112054-667390E4-BDF1-4F87-82DC-E76FA7ED7488

Q35112054-822A6284-E6F1-4C95-A05C-BBAED9C613C4

P304

Q35112054-1270283B-17AA-4A95-9D99-C34FF36C79D6

P31

Q35112054-B708BC81-3149-453C-8F34-E701D4655888

P356

Q35112054-8D3AB9B0-6C59-4206-A0D2-6BE1AD09DBE6

P407

Q35112054-A0E9948D-6031-479D-A006-8443923D9700

P433

Q35112054-77A33099-65AC-4F21-8155-D0EB46323672

P478

Q35112054-DCA5CF4E-D5F0-4539-82E9-13AFE7D45944

P50

Q35112054-2AFCF2BB-8F95-430A-AD90-B70518900BB7

Q35112054-A400AB6E-65A1-4AC9-A198-94497181B913

P577

Q35112054-21DBC219-EA6B-4319-B0D6-071C67F7DC94

P5875

Q35112054-36485346-BF1B-4B2C-A891-4F96521C8B02

P698

Q35112054-2A9B3E7E-2D0C-4426-89E3-8F1740E994C9

P932

Q35112054-CE37AB0D-250B-4FD9-8F08-5E46AE81F604

P356

JOURNAL.PONE.0090133

P1433

P1476

Nanostring-based multigene ass ...... cancer patients after surgery

@en

P2093

Byung Hoon Min

http://www.w3.org/2001/XMLSchema#string

Do Hoon Lim

http://www.w3.org/2001/XMLSchema#string

Dong Il Choi

http://www.w3.org/2001/XMLSchema#string

Ho Yeong Lim

http://www.w3.org/2001/XMLSchema#string

Iain Beehuat Tan

http://www.w3.org/2001/XMLSchema#string

In-Gu Do

http://www.w3.org/2001/XMLSchema#string

Insuk Sohn

http://www.w3.org/2001/XMLSchema#string

Jae J Kim

http://www.w3.org/2001/XMLSchema#string

Jae Moon Bae

http://www.w3.org/2001/XMLSchema#string

Jeeyun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas

Direct multiplexed measurement of gene expression with color-coded probe pairs

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

A versatile assay for high-throughput gene expression profiling on universal array matrices

Proteomic analysis revealed a strong association of a high level of alpha1-antitrypsin in gastric juice with gastric cancer.

Biomarker discovery for colon cancer using a 761 gene RT-PCR assay.

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

P304

e90133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0090133

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Poong-Lyul Rhee

P577

2014-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260562556

http://www.w3.org/2001/XMLSchema#string

P698

24598828

http://www.w3.org/2001/XMLSchema#string

P932

3943911

http://www.w3.org/2001/XMLSchema#string